Literature DB >> 28688773

New vaccination strategies in liver cancer.

Luigi Buonaguro1.   

Abstract

Entities:  

Keywords:  HCC; HEPAVAC; HLA-ligandome; cancer vaccine

Mesh：

Substances：

Year:  2017        PMID： 28688773     DOI： 10.1016/j.cytogfr.2017.06.010

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN： 1359-6101            Impact factor:   7.638


× No keyword cloud information.
  5 in total

Review 1.  Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects.

Authors:  Cheng Zhong; Yirun Li; Jing Yang; Shengxi Jin; Guoqiao Chen; Duguang Li; Xiaoxiao Fan; Hui Lin
Journal:  Front Oncol       Date:  2021-03-29       Impact factor: 6.244

2.  Novel Molecular Targets for Hepatocellular Carcinoma.

Authors:  Beatrice Cavalluzzo; Angela Mauriello; Concetta Ragone; Carmen Manolio; Maria Lina Tornesello; Franco M Buonaguro; Siri Amanda Tvingsholm; Sine Reker Hadrup; Maria Tagliamonte; Luigi Buonaguro
Journal:  Cancers (Basel)       Date:  2021-12-28       Impact factor: 6.639

Review 3.  Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?

Authors:  David Repáraz; Belén Aparicio; Diana Llopiz; Sandra Hervás-Stubbs; Pablo Sarobe
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

Review 4.  Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).

Authors:  Paolo A Ascierto; James Brugarolas; Luigi Buonaguro; Lisa H Butterfield; David Carbone; Bruno Daniele; Robert Ferris; Bernard A Fox; Jérôme Galon; Cesare Gridelli; Howard L Kaufman; Christopher A Klebanoff; Ignacio Melero; Paul Nathan; Chrystal M Paulos; Marco Ruella; Ryan Sullivan; Hassane Zarour; Igor Puzanov
Journal:  J Immunother Cancer       Date:  2018-07-11       Impact factor: 13.751

Review 5.  Recent Advances in Immunotherapy for Hepatocellular Carcinoma.

Authors:  Shigeharu Nakano; Yuji Eso; Hirokazu Okada; Atsushi Takai; Ken Takahashi; Hiroshi Seno
Journal:  Cancers (Basel)       Date:  2020-03-25       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.